VialTirzepatide
Tirzepatide (LY3298176)
Tirzepatide is a dual GIP and GLP-1 receptor agonist studied in glycemic and body-composition research.
Third-party tested · Purity 99% · For laboratory research use only.
- Purity
- 99%
- Form
- Powder (lyophilized)
- Available sizes
- 40mg
Mechanism of Action
Research shows combined GIP/GLP-1 receptor agonism enhances insulin sensitivity, satiety signaling and lipid handling.
Research Areas
- ●Glycemic control research
- ●Appetite and satiety studies
- ●Metabolic syndrome models